DE60141898D1 - VERBINDUNG, ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON ENTZüNDLICHEN UND ENTZüNDUNGS-VERWANDTEN ERKRANKUNGEN - Google Patents

VERBINDUNG, ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON ENTZüNDLICHEN UND ENTZüNDUNGS-VERWANDTEN ERKRANKUNGEN

Info

Publication number
DE60141898D1
DE60141898D1 DE60141898T DE60141898T DE60141898D1 DE 60141898 D1 DE60141898 D1 DE 60141898D1 DE 60141898 T DE60141898 T DE 60141898T DE 60141898 T DE60141898 T DE 60141898T DE 60141898 D1 DE60141898 D1 DE 60141898D1
Authority
DE
Germany
Prior art keywords
inflammatory
rna
yeast
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60141898T
Other languages
English (en)
Inventor
Zenoviy Tkachuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocell Laboratories Inc
Original Assignee
Biocell Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocell Laboratories Inc filed Critical Biocell Laboratories Inc
Application granted granted Critical
Publication of DE60141898D1 publication Critical patent/DE60141898D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60141898T 2000-03-24 2001-03-26 VERBINDUNG, ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON ENTZüNDLICHEN UND ENTZüNDUNGS-VERWANDTEN ERKRANKUNGEN Expired - Lifetime DE60141898D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/534,509 US6737271B1 (en) 2000-03-24 2000-03-24 Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders
PCT/US2001/009590 WO2001073003A1 (en) 2000-03-24 2001-03-26 Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders

Publications (1)

Publication Number Publication Date
DE60141898D1 true DE60141898D1 (de) 2010-06-02

Family

ID=24130363

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60141898T Expired - Lifetime DE60141898D1 (de) 2000-03-24 2001-03-26 VERBINDUNG, ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON ENTZüNDLICHEN UND ENTZüNDUNGS-VERWANDTEN ERKRANKUNGEN

Country Status (9)

Country Link
US (1) US6737271B1 (de)
EP (1) EP1278836B1 (de)
CN (1) CN1451041B (de)
AT (1) ATE465254T1 (de)
AU (1) AU2001252964A1 (de)
DE (1) DE60141898D1 (de)
EA (1) EA010182B1 (de)
UA (1) UA66416C2 (de)
WO (1) WO2001073003A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153839B2 (en) * 2000-03-24 2006-12-26 Biocell Laboratories Method of protecting erythricytes, in particular for improvement of blood cytopenia
DE10309368A1 (de) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase
DE10242016A1 (de) * 2002-09-11 2004-03-25 Esplora GmbH c/o TU Darmstadt Institut für Biochemie Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon
IT1391866B1 (it) * 2008-10-30 2012-01-27 Mastelli S R L Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari.
US8420617B2 (en) 2011-03-11 2013-04-16 Biocell Laboratories Multiantivirus compound, composition and method for treatment of virus diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615654A (en) * 1968-05-17 1971-10-26 Cpc International Inc Method of treating microbial cells
US3914450A (en) * 1973-04-09 1975-10-21 Anheuser Busch Concentrated extract of yeast and processes of making same
JPH07509133A (ja) * 1992-07-17 1995-10-12 リボザイム・ファーマシューティカルズ・インコーポレイテッド 動物疾患の処置のための方法および剤
AU7319994A (en) 1993-06-30 1995-01-24 Board Of Regents, The University Of Texas System Nucleotide preparation and uses thereof in wound healing

Also Published As

Publication number Publication date
WO2001073003A1 (en) 2001-10-04
CN1451041A (zh) 2003-10-22
CN1451041B (zh) 2010-06-16
AU2001252964A1 (en) 2001-10-08
EA010182B1 (ru) 2008-06-30
EP1278836A1 (de) 2003-01-29
EP1278836A4 (de) 2004-07-07
EA200201015A1 (ru) 2003-06-26
ATE465254T1 (de) 2010-05-15
EP1278836B1 (de) 2010-04-21
UA66416C2 (en) 2004-05-17
US6737271B1 (en) 2004-05-18

Similar Documents

Publication Publication Date Title
Harris et al. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production
Thappa et al. Nodulocystic acne: oral gugulipid versus tetracycline
HUP9902103A2 (hu) Triarilvegyületek
HK1057899A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
CA2219115A1 (en) N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
HUP0002296A2 (hu) Sertralinsók és a sertralin elnyújtott felszabadulását biztosító dózisformák
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
FR2364030A1 (fr) Compositions pharmaceutiques a base d'anthocyanidines et procede pour leur preparation
ATE548354T1 (de) Ureido-substituierte benzoesäureverbindungen und ihre verwendung für die nonsense-suppression und behandlung von erkrankungen
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
ATE361909T1 (de) Substituierte gamma-aminobuttersäurederivate als arzneimittel
HUP0401867A2 (hu) A valproinsav-amid és a 2-valproénsav-amid származékainak használata a fájdalommal és a fejfájással járó betegségek kezelésére vagy megelőzésére
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE406371T1 (de) Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung
RU2007138263A (ru) Противовоспалительные соединения
DE60141898D1 (de) VERBINDUNG, ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON ENTZüNDLICHEN UND ENTZüNDUNGS-VERWANDTEN ERKRANKUNGEN
AT509045B1 (de) Verbindungen zur behandlung von asthma bronchiale
WO1992013540A1 (fr) Onguent antalgique
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
BE886486A (fr) Forme pharmaceutique "gel" contenant l'acide 2-(3-benzoyl-phenyl)-propionique et son utilisation en therapeutique pour un usage local
DE60107505D1 (de) Wirksame Derivate der Valproinsäure zur Behandlung von neurologischen und psychotischen Störungen, und ein Verfahren zu ihrer Herstellung
EP3164110B1 (de) Pharmazeutische zusammensetzungen zur behandlung von psoriasis
WO2000067732A3 (de) Pharmazeutische zusammensetzung enthaltend antimykotikum, polydocanol und salycylsaüre

Legal Events

Date Code Title Description
8364 No opposition during term of opposition